Utilità Clinica Del Dosaggio Dell'Antigene Prostatico Specifico (Psa)

Ahraan F.R. , Schifman R.B. : Prospective comparison between serum monoclonal prostate specific antigen and phosphatase measurements in metastatic prostatic cancer. J. Urol., 137; 431 (1987).

Aiello E. , Maver P. , Mannini D. , Vecchi F. , Bellanova B. : Il dosaggio dell'antigene prostatico specifico sierico nella patologia prostatica: esperienza con il metodo radioimmunologico. Arch. Ital. Urol., 58; 15–23 (1986).

Andreassi F. , Borboni P. , D'Alpaos M. , Manca P. , Piras P. : Utilità dell'antigene prostatico specifico nella diagnostica delTadenocarcinoma della prostata. Urologia, 53; 567 (1986).

Breda G. , Xausa D. , Gherardi L. , Tamai A. , Silvestre P. , Pulido E. : Variazione del PSA, CA 50, fosfatasi acida totale e prostatica dopo esplorazione rettale della prostata. Acta Urol. Ital., 3; 29–31 (1989).

Chan D.W. , Bruzek D.J. , Oesterling J.E. , Rock R.C. , Walsh P.C. : Prostate-specific antigen as a marker for prostatic cancer: a monoclonal and a polyclonal immunoassay compared. Clin. Chem., 33; 1916 (1987).

Ercole C.J. , Lange P.H. , Mathisen M. , Chiou R.H. , Reddy P.K. , Vessella R.L. : Prostatic antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer. J. Urol., 138; 1181 (1987).

Ferro M.S. , Barnes I. , Roberts J.B.M. , Smith P.B. : Tumour marker in prostatic carcinoma. A comparison of prostate-specific antigen with acid phosphatase. Brit. J. Urol., 60; 69–73 (1987).

Fornarola S. , Voce S. : Determinazione radioimmunologica del PSA nella diagnosi e nel follow up del carcinoma prostatico: revisione critica. 62° Congr. Nazionale S.I.U., Firenze 1989.

Guinan P. , Bhatti R. , Ray P. : An evaluation of prostate specific antigen in prostate cancer. J. Urol., 137; 686 (1987).

Hortin G.L. , Bahnson R.R. , Daft M. , Chan K.M. , Catalona W.J. , Ladenson J.K. : Differences in values obtained with 2 assays of prostate-specific antigen. J. Urol., 139; 762 (1988).

Kuriyama M. , Wang M.C. , Lee C.L. , Papsidero L.C. , Killian C.S. , Ianji H. , Slack N.H. , Murphy G.P. : Use of human prostate-specific antigen in monitoring of prostate cancer. Cancer Res., 41; 3874 (1981).

Kuriyama M. , Wang M.C. , Papsidero L.D. , Killian C.S. , Shimano T. , Valenzuela L. , Murphy G.P. , Chu T.M. : Quantification of prostate-specific antigen in serum by a senstive enzyme. Cancer Res., 40; 4658 (1980).

Liedtke R.J. , Batier J.D. : Measurement of prostatic specific antigen by radioimmunoassay. Clin. Med., 30; 652 (1984).

Lo Bianco A. , Tomasino R.M. , Carreca I. , Cacciatore M. , Pavone C. , Pavone Macaluso M. : Correlazione fra valori di PSA sierico e tissutale e loro significato prognostico nel carcinoma prostatico. 62° Congr. Nazionale S.I.U., Firenze 1989.

Mannini D. , Aiello E. , Maver P. , Corrado G. , Vecchi F. , Bellanova B. , Marengo M. : Serch for spontaneous circadian varia tions in serum prostate specific antigen and prostatic acid phosphatase activity in patients with prostatic cancer: a preliminary report. J. Endrocinol. Invest., 10; Suppl. 2, 48 (1987).

Mannini D. , Aiello E. , Maver P. , Corrado G. , Vecchi F. , Bellanova B. , Marengo M. : La determinazione del PSA sierico nel carcinoma della prostata: considerazioni su 130 casi. Acta Urol. Ital., 2; 69–72 (1988).

Oesterling J.E. , Bruzek D.J. , Chan D.W. , Epstein J.D. , Kimball A.W. jr. , Rock R.C. , Brendler C.B. , Walsh P.C. : The value of prostatic specific antigen in the management of adenocarcinoma of the prostate. Abstracts 1987 AUA Meeting. J. Urol., 137; 194 A (1987).

Oesterling J.E. , Chan D.W. , Epstein J.D. , Kimball A.W. jr. , Bruzek D.J. , Rock R.C. , Brendler C.B. , Walsh P.C. : Prostate specific antigen in the preoperative and postoperative evalutaion of localized prostatic cancer treated with radical prostatectomy. J. Urol., 139; 766 (1988).

Papsidero L.D. , Kuriyama M. , Wang M.C. , Horoszewicz J. , Leong S.S. , Valenzuela L.A. , Murphy G.P. , Chu T.M. : Prostate antigen: a marker for human prostate epithelial cells. JNCI, 66; 37 (1981).

Rock R.C. , Chan D.W. , Bruzek D.J. , Waldrom C.E. , Oesterling J.E. , Walsh P.C. : Evaluation of a monoclonal immunoradiometric assay for prostate-specific antigen. Clin. Chem., 33; 2257 (1987).

Sevin G. , Ihsan Tasci A. : Prostate specific antigen (a new tumor marker) in prostatic carcinoma. 1° Mediterranean Congr. Urol., Rome 1989.

Siddal G.K. , Shetty S.D. , Cooper E.H. : Measurements of serum gamma-seminoprotein and prostate specific antigen evaluated for monitoring carcinoma of the prostate. Clin. Chem., 32; 2040 (1986).

Stamey T.A. , Yang N. , Hay A.R. , Mc Neal J.E. , Freiha F.S. , Redwine E. : Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. NEJM, 317; 909 (1987).

Vernon S.E. , Williams W.D. : Pre-treatment post-treatment evaluation of prostatic adenocarcinoma for prostatic specific acid phosphatase and prostatic specific antigen by immunohistochemistry. J. Urol., 130; 95 (1983).

Wang T.Y. , Kawaguchi T.P. : Preliminary evaluation of measurement of serum prostate-specific antigen level in detection of prostate cancer. Ann. Clin. Lab. Sci., 16; 461 (1986).

Wang M.C. , Valenzuela L.A. , Murphy G.P. , Chu T.M. : Purification of a human prostate specific antigen. Invest. Urol., 17; 159 (1979).

Weber J.P. , Oesterling J.E. , Peters C.A. , Partin A.W. , Chan D.W. , Walsh P.C. : The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia. J. Urol., 141; 987 (1989).